Serum vascular adhesion protein-1 level is higher in smokers than non-smokers

References

• Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L. 2004. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47:429–438
   PubMed Web of Science ®Google Scholar
• American Diabetes Associations. 1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
   Google Scholar
• Boomsma F, Bhaggoe UM, Van Der Houwen AM, Van Den Meiracker AH. 2003. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta 1647:48–54
   PubMed Web of Science ®Google Scholar
• Chahine T, Subramanian SV, Levy JI. 2011. Sociodemographic and geographic variability in smoking in the U.S.: a multilevel analysis of the 2006--2007 Current Population Survey, Tobacco Use Supplement. Soc Sci Med 73:752–758
   PubMed Web of Science ®Google Scholar
• Csordas A, Kreutmayer S, Ploner C, Braun P, Karlas A, Backovic A, Wick G, Bernhard D. 2011. Cigarette smoke extract induces prolonged endoplasmic reticulum stress and autophagic cell death in human umbilical vein endothelial cells. Cardiovasc Res 92:141–148
   PubMed Web of Science ®Google Scholar
• Diamandis EP. 1988. Immunoassays with time-resolved fluorescence spectroscopy: principles and applications. Clin Biochem 21:139–150
   PubMed Web of Science ®Google Scholar
• Diamandis EP, Morton RC. 1988. Time-resolved fluorescence using a europium chelate of 4,7-bis-(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA). Labeling procedures and applications in immunoassays. J Immunol Methods 112:43–52
   PubMed Web of Science ®Google Scholar
• Ekblom J, Gronvall J, Lennernas B, Nilsson S, Garpenstrand H, Oreland L. 1999. Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer. Clin Sci (Lond) 97:111–115
   PubMed Web of Science ®Google Scholar
• Garcia-Vicente S, Abella A, Viguerie N, Ros-Baro A, Camps M, Testar X, Palacin M, et al. 2005. The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha. J Physiol Biochem 61:395–401
   PubMed Web of Science ®Google Scholar
• Garpenstrand H, Bergqvist M, Brattstrom D, Larsson A, Oreland L, Hesselius P, Wagenius G. 2004. Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients. Med Oncol 21:241–250
   PubMed Web of Science ®Google Scholar
• Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Soderberg C, Israelson M, et al. 2003. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol 163:1921–1928
   PubMed Web of Science ®Google Scholar
• Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. 2005. An alternative formula to the Cockcroft--Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol 16:1051–1060
   PubMed Web of Science ®Google Scholar
• Jalkanen S, Karikoski M, Mercier N, Koskinen K, Henttinen T, Elima K, Salmivirta K, Salmi M. 2007. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 110:1864–1870
   PubMed Web of Science ®Google Scholar
• Kim KS, Park HS, Jung IS, Park JH, Ahn KT, Jin SA, Park YK, et al. 2011. Endothelial dysfunction in the smokers can be improved with oral cilostazol treatment. J Cardiovasc Ultrasound 19:21–25
   PubMedGoogle Scholar
• Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. 2000. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119:1096–1103
   PubMed Web of Science ®Google Scholar
• Li HY, Jiang YD, Chang TJ, Wei JN, Lin MS, Lin CH, Chiang FT, et al. 2011. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes 60:993–999
   PubMed Web of Science ®Google Scholar
• Li HY, Lin MS, Wei JN, Hung CS, Chiang FT, Lin CH, Hsu HC, et al. 2009a. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects. Clin Chim Acta 403:97–101
   PubMed Web of Science ®Google Scholar
• Li HY, Wei JN, Lin MS, Smith DJ, Vainio J, Lin CH, Chiang FT, et al. 2009b. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 404:149–153
   PubMed Web of Science ®Google Scholar
• Lin MS, Li HY, Wei JN, Lin CH, Smith DJ, Vainio J, Shih SR, et al. 2008. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem 41:1362–1367
   PubMed Web of Science ®Google Scholar
• Marttila-Ichihara F, Auvinen K, Elima K, Jalkanen S, Salmi M. 2009. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1 + CD11b+ myeloid cells into tumors. Cancer Res 69:7875–7883
   PubMed Web of Science ®Google Scholar
• Mazzone T, Chait A, Plutzky J. 2008. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371:1800–1809
   PubMed Web of Science ®Google Scholar
• Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S. 2005. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 166:793–800
   PubMed Web of Science ®Google Scholar
• Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, et al. 2002. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 161:2255–2262
   PubMed Web of Science ®Google Scholar
• Salminen TA, Smith DJ, Jalkanen S, Johnson MS. 1998. Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng 11:1195–1204
   PubMedGoogle Scholar
• Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S, Senges J, et al. 2011. Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100:413–423
   PubMed Web of Science ®Google Scholar
• Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S. 2004. Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 95:50–57
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M. 2009. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol 99:368–372
   PubMed Web of Science ®Google Scholar
• Yu PH. 1998. Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity. Neurochem Res 23:1205–1210
   PubMed Web of Science ®Google Scholar
• Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D. 2003. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647:193–199
   PubMed Web of Science ®Google Scholar